NextCell Pharma AB (STO:NXTCL)
1.266
-0.060 (-4.52%)
Mar 9, 2026, 5:14 PM CET
-64.24% (1Y)
| Market Cap | 147.71M |
| Revenue (ttm) | 9.83M |
| Net Income (ttm) | -38.79M |
| Shares Out | 111.39M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 195,101 |
| Average Volume | 287,942 |
| Open | 1.310 |
| Previous Close | 1.326 |
| Day's Range | 1.250 - 1.310 |
| 52-Week Range | 0.630 - 3.600 |
| Beta | 0.72 |
| RSI | 46.86 |
| Earnings Date | May 28, 2026 |